MEBIS, Jeroen

Email Alert RSS Feed

Profile

Full Name
MEBIS, Jeroen
Email
jeroen.mebis@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 71-87 of 87 (Search time: 0.005 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
712015Evaluation of the effect of low level laser therapy on oral mucositis in breast cancer patients: A retrospective analysisMEBIS, Jeroen; Censabella, S.; MAES, Annelies; Noé, L.; BULENS, PaulJournal ContributionM
722014LOW LEVEL LASER THERAPY FOR THE MANAGEMENT OF RADIATION DERMATITIS: PRELIMINARY RESULTS OF A PILOT STUDY IN BREAST CANCER PATIENTSCENSABELLA, S.; ROBIJNS, Jolien; CLAES, S.; BULENS, Paul; MEBIS, JeroenJournal ContributionM
732014Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapyBatair, A.; Van Fraeyenhoven, F.; Vandebroek, A.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
742013‘Screening cancer patients distress and care needs: translation and validation of the Cancer Rehabilitation Evaluation System (CARES) for the Flemish population in Belgium.’SCHOUTEN, Bojoura; VAN HOOF, Elke; Vankrunkelsven, Patrick; BULENS, Paul; MEBIS, Jeroen; Vandenborre, Katherine; HELLINGS, JohanConference MaterialC2
752013Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case reportVan Ginderachter, Laura; Cox, Tony; Drijkoningen, Ria; ACHTEN, Ruth; Joosens, Eric; Maes, Annelies; Theunissen, Koen; MEBIS, JeroenJournal ContributionA2
762013Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancerBaitar, A.; van Fraeyenhove, F.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen; Schrijvers, D.Journal ContributionA1
772012The 2006 Adjuvant Trastuzumab Convention in Belgium: 5 years laterVanderhaegen, J.; Paridaens, R.; Piccart, M.; Lalami, Y.; Machiels, J.P.; Jerusalem, G.; Borms, M.; Goemine, J.; MEBIS, Jeroen; Dirix, L.; Lintermans, A.; Brouckaert, O.; Neven, P.Conference MaterialC2
782012Will ‘fit’ older cancer patients as assessed by frailty screening tools tolerate the first cycle of (radio)chemotherapy without serious adverse events?MEBIS, JeroenConference MaterialC2
792012Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment).Wolter, Pascal; Hendrickx, Tine; Renard, Vincent; MEBIS, Jeroen; Debruyne, Philip R.; Wynendaele, Wim; Schallier, Denis C. C.; Vermeij, Joanna; Nielander, Aldrik; Machiels, Jean-Pascal H.; Rottey, Sylvie; Delande, Stephanie; Goeminne, Jean-Charles; Schoffski, Patrick; De Coster, Sandra; Lacour, Valerie; Foulon, VeerleJournal ContributionM
802012Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST TrialLlombart, Antonio; Frassoldati, Antonio; Paija, Outi; Sleeboom, Harm Peter; Jerusalem, Guy; MEBIS, Jeroen; Deleu, Ines; Miller, Joel; Schenk, Nora; Neven, PatrickJournal ContributionA1
812012Metabolic phenotype by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
822012METABOLIC PHENOTYPE BY NMR SPECTROSCOPY: A BIOMARKER FOR LUNG CANCERLOUIS, Evelyne; REEKMANS, Gunter; BAETEN, Kurt; MESOTTEN, Liesbet; THOMEER, Michiel; VANHOVE, Karolien; MEBIS, Jeroen; Vandeurzen, Kurt; Darquennes, Karen; ADRIAENSENS, PeterConference MaterialC2
832011Metabolic phenotyping by NMR spectroscopy: A biomarker for lung cancerLOUIS, Evelyne; BAETEN, Kurt; Vandeurzen, Kurt; VANHOVE, Karolien; Darquennes, Karen; MESOTTEN, Liesbet; THOMEER, Michiel; DE JONGE, Eric; VAN DER SPEETEN, Kurt; MEBIS, Jeroen; ADRIAENSENS, PeterConference MaterialC2
842010Melanoma incidence trends in Limburg after screening and prevention campaignsVanstraelen, D.; Deleu, H.; VAN ROBAYS, Johan; DHollander, D.; CLOES, Edith; Lousberg, D.; Kuijpers, G.; ADRIAENS, Brecht; MEBIS, Jeroen; Mathei, Catharina; Buntinx, F.Journal ContributionA2
152010Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematological malignancy after antibiotic change: a single centre prospective study with 15 years of follow-upMEBIS, Jeroen; Jansens, Hilde; AYELE, Girma; MOLENBERGHS, Geert; Schroyens, W.; Gadisseur, Alain; Van de Velde, An L. R.; Vrelust, Inge; Goossens, Herman; Berneman, Zwi N.Journal ContributionA1
162005Pseudo-thrombopenie. Een niet altijd even goed gekend laboartoriumfenomeen.De Greef, Y.; Claeys, R.; MEBIS, Jeroen; Janssen, M.; Vanstraelen, D.; Madoe, V.; RUMMENS, Jean-Luc; Bries, G.Journal ContributionA1
172005Oncologische revalidatie : een stap voorwaarts in een kwaliteitsvolle zorg van de kankerpatiëntDe Greef, Y.; DENDALE, Paul; CLAES, Guido; Vanstraelen, D.; Madoe, V.; Bries, G.; MAES, Annelies; Brosens, M.; BULENS, Paul; MEBIS, JeroenJournal ContributionA1
show all